HHT is classified as an autosomal dominant disorder, and data from formal genetics have been confirmed by the demonstration of heterozygous mutations in three main genes: ACVRL1, ENG, and SMAD4. Here, SMAD4 is linked to hereditary hemorrhagic telangiectasia.